GSK sells rabies and ticks vaccines for nearly €1bn

The Aquafresh and Panadol drugs business GSK has sold two of its travel vaccines for up to €955 million, the company has announced.
GSK said it will receive an upfront payment of €301m with the rest depending on certain sales targets being hit.